Dr Nicolas Hart
PhD, MSc, BSc.
Dr Nicolas Hart, AES, CSCS, ESSAM is a post-doctoral research fellow at the Exercise Medicine Research Institute (an NHMRC Centre of Research Excellence) and an accredited exercise scientist at Edith Cowan University. His clinical oncology work focuses on the ability of exercise to change tumour biology, and attenuate tumour formation, growth and invasion in primary and secondary carcinomas. Dr Hart is currently leading a series of world-first, trials in humans to examine the suppressive or regressive effects of exercise on tumour morphology and tumour biomarkers in secondary carcinomas of advanced prostate and breast cancer patients with sclerotic and osteolytic spinal lesions. Dr Hart is the Global Exercise Co-ordinator for the Movember GAP4 (INTERVAL-MCRPC) trial - (the largest exercise trial in prostate cancer worldwide; investigating exercise and overall survival); and National Exercise Co-ordinator for the Movember TrueNTH Australia trial - (the provision of local and remote delivery of exercise as medicine to prostate cancer patients across metropolitan and regional Australia). Dr Hart is also a founding member of the Western Australian Bone Research Collaboration (WABRC): a cross-institutional and multidisciplinary team of researchers and clinicians investigating bone health and disease.
Dr Hart is a consultant sport scientist to the West Coast Eagles, Fremantle Dockers, Western Force and Perth Glory sporting teams to provide input towards, and assist in the prevention and management of stress-related bone injuries; stratify musculoskeletal injury risk; and provide a broad range of sport science services on request.